BDCA2 (Blood Dendritic Cell Antigen 2), also known as CLEC4C (C-type lectin domain family 4 member C), is a C-type lectin-like receptor specifically expressed on plasmacytoid dendritic cells (pDCs). BDCA2 plays a critical role in regulating the immune functions of pDCs, particularly in antiviral immunity, the production of type I interferons, and maintaining immune homeostasis.
Genomeditech provides functional cell lines, expression cell lines, proteins, and antibodies related to the BDCA2 target, supporting the activity validation and in vitro efficacy evaluation of BDCA2-related drugs.